Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 ...
(“AV”) (NASDAQ: AVAV), a global defense technology leader, today announced it has been awarded a three-year, $500 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract in support of Joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results